PARP and Androgen-Signaling Inhibition plus ADT in Metastatic Prostate Cancer. Agarwal N, Matsubara N, Azad AA, Saad F, et al. N Engl J Med 2026 May 30. doi: 10.1056/NEJMoa2604126.

Read + Share

Amedeo Smart

Independent Medical Education

Agarwal N, Matsubara N, Azad AA, Saad F, et al. PARP and Androgen-Signaling Inhibition plus ADT in Metastatic Prostate Cancer. N Engl J Med 2026 May 30. doi: 10.1056/NEJMoa2604126.
PMID: 42223064